![netspot injection netspot injection](https://www.rad.pitt.edu/sites/rad_image/feed/ga1.png)
![netspot injection netspot injection](https://www.virtualcongress.adacap.com/img/netspot_thumbnail.png)
is committed and looking forward to serving patients and nuclear medicine departments with the preparation and delivery of NETSPOT™. Wayne Wong, Vice President of Product Development for NDP noted, “Nuclear Diagnostic Products, Inc. With our large pharmacy network, we continue to provide world renowned technical expertise in the compounding and delivery of radiopharmaceuticals.” Marc Pfefferle, Chief Executive Officer of Triad stated, “We are excited about this opportunity and the ability to provide the benefits of NETSPOT™ to our customers. The addition of these partnerships completes the foundation of a robust nationwide supply chain that now includes four radiopharmacy networks. Triad and NDP will each prepare and deliver NETSPOT TM patient doses to advanced medical imaging sites in selected metropolitan areas. The product has received orphan drug designation from the FDA. Food and Drug Administration (“FDA”) for the preparation of Ga 68 dotatate for injection, for the localization of somatostatin receptor positive neuroendocrine tumors (“NETs”) in adult and pediatric patients using Positron Emission Tomography (“PET“). NETSPOT TM (formerly known as Somakit-TATE) is a patented kit recently approved by the U.S. (“UPPI”), to supply gallium 68 (“Ga 68”) dotatate doses prepared with a novel kit to U.S. (“NDP”), a company with three radiopharmacies in the Northeast and a member of United Pharmacy Partners Inc. supply chain for NETSPOT TM with the addition of two radiopharmacy networks, Triad Isotopes, Inc., the second largest radiopharmaceutical company in the United States, and Nuclear Diagnostic Products, Inc. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in Molecular Nuclear Medicine (MNM), today announced that it has further strengthened its U.S.
![netspot injection netspot injection](https://s3-eu-west-1.amazonaws.com/s3-adacap-product/wp-content/uploads/2018/11/26130303/Adacap-Lutathera94856-etic-267x300.jpg)
Saint-Genis-Pouilly, France (GLOBE NEWSWIRE) - Advanced Accelerator Applications S.A.